Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:00767'
s ROE % Range Over the Past 10 Years
Min: -77.19 Med: -0.95 Max: 7.86
Current: -4.27
During the past 13 years, Zhong Ji Longevity Science Group's highest ROE % was 7.86%. The lowest was -77.19%. And the median was -0.95%.
HKSE:00767's ROE % is ranked worse than 56.78% of 199
companies
in the Medical Diagnostics & Research industry
Industry Median: -0.56
vs HKSE:00767: -4.27
Zhong Ji Longevity Science Group (HKSE:00767) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Zhong Ji Longevity Science Group ROE % Related Terms
Zhong Ji Longevity Science Group ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Zhong Ji Longevity Science Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhong Ji Longevity Science Group ROE % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Zhong Ji Longevity Science Group's ROE % distribution charts can be found below:
* The bar in red indicates where Zhong Ji Longevity Science Group's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Zhong Ji Longevity Science Group (HKSE:00767) has a ROE % of -2.08% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Zhong Ji Longevity Science Group and its competitors. According to the industry distribution chart, Zhong Ji Longevity Science Group ranks #113 out of 199 companies in the Medical Diagnostics & Research industry, placing it in the top 56.8%.
Is Zhong Ji Longevity Science Group's ROE % too high?
Zhong Ji Longevity Science Group's current ROE % is -2.08%. Based on the distribution chart, Zhong Ji Longevity Science Group ranks #113 out of 199 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Zhong Ji Longevity Science Group has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhong Ji Longevity Science Group's ROE % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Zhong Ji Longevity Science Group ranks #113 out of 199 companies for ROE %. This places Zhong Ji Longevity Science Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Diagnostics & Research company?
A good ROE % depends on the Medical Diagnostics & Research industry context. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Zhong Ji Longevity Science Group and its competitors. Zhong Ji Longevity Science Group's current ROE % is -2.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhong Ji Longevity Science Group stock overvalued right now?
Based on GuruFocus' analysis, Zhong Ji Longevity Science Group (HKSE:00767) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.89, compared to a current price of HK$0.36 — trading 59.6% below its estimated fair value. The current ROE % is -2.08%. Zhong Ji Longevity Science Group's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Zhong Ji Longevity Science Group (HKSE:00767), the current ROE % is -2.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhong Ji Longevity Science Group (HKSE:00767) Overvalued in 2026?
Based on GuruFocus' analysis, Zhong Ji Longevity Science Group stock appears to be undervalued.
The current stock price of HK$0.36 is trading 59.6% below its estimated GF Value™ of HK$0.89.
GuruFocus considers Zhong Ji Longevity Science Group to be Possible Value Trap.
Key valuation signals for HKSE:00767:
ROE %: -2.08%
GF Value™: HK$0.89 vs. price of HK$0.36 (59.6% below fair value)
No single metric tells the full story. See the HKSE:00767 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhong Ji Longevity Science Group Ltd is an investment holding company. Through its subsidiaries, it engages in Longevity science business, Money lending and Financial Advisory, Securities and other investments, and Property investment. The company generates the majority of its revenue from the Longevity Science business. The Longevity science business includes the provision of diagnostic consultation, health and medical testing and checking, distribution of cancer prevention & immunity healthcare supplements, and the sales and distribution of longevity wine.
55GF Score
Get the complete analysis for HKSE:00767
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00767 has been successfully added to your 
